taj pharmaceutical mumbai supplier, active pharmaceutical taj phamra manufacturers, pharmaceutical taj exporter

taj pharmaceutical mumbai supplier, active pharmaceutical taj phamra manufacturers, pharmaceutical taj exporter

Providing products and services to treat and monitor diseases is at the core of Taj Pharmaceutical's activities in all major therapeutic areas. Our product range makes it possible to offer real improvements to doctors, hospitals and patiensts.

For many of these areas and the corresponding indications, Taj Pharmaceuticals has provided a large range of therapeutic options. Please view a selection of major prescription drugs by accessing the current Selected Products overview.

Taj Pharmaceuticals is one of the world’s leading innovation-driven healthcare groups. Its core businesses are pharmaceuticals and diagnostics. Taj Pharmaceuticals is number one in the global diagnostics market and is the leading supplier of pharmaceuticals for cancer and a leader in virology and transplantation. As a supplier of products and services for the prevention, diagnosis and treatment of disease, the Group contributes on a broad range of fronts to improving people’s health and quality of life. Taj Pharmaceuticals employs roughly 65,000 people in 150 countries.

Taj Pharmaceutical's pioneering approach to healthcare innovation enables us to deliver significant benefits to patients as well as to healthcare providers and systems. In our vision of the future, therapies will be available for many of today's untreatable diseases, it will be possible to optimize drug efficacy and safety, and effective strategies will be in place for preventing disease. Early diagnosis and improved new treatments will significantly reduce the need for expensive surgical operations and long hospital stays.

Generic	Therapeutic Category	Strengths	Dosage
Anastrozole	Breast cancer	1mg	Tablets
Axitinib	Renal cell carcinoma,Pancreatic cancer,Breast cancer.	1mg / 5mg	Tablets
Azathioprine Sodium	Immunosuppresant,Autoimmune	25mg / 50mg	Tablets
Bicalutamide	Prostate cancer	50mg /150mg	Tablets
Busulfan	Chronic lymhocytic leukemia	2mg / 4mg	Tablets
Capecitabine	Metastatic breast & colorectal cancers	150mg / 500mg	Tablets
Chlorambucil	Chronic lymphocyctic leukemia	1mg / 2mg & 5mg	Tablets
Colchicine	Acute gout diseases	0.5mg / 0.6mg / 500mcg	Tablets
Cyclophosphamide	Different cancers & Auto immune disorders	25mg / 50mg / 100mg	Tablets
Dasatinib	Prostate cancer	20mg / 50mg / 70mg / 80mg / 100mg / 140mg	Tablets
Deferasirox	Chronic iron chelator	100 mg / 250mg / 400 mg / 500mg	Tablets
Erlotinib Hydrochloride	Pancreatic,non-small cell lung cancer.	25 mg / 100mg / 150mg	Tablets
Everolimus	Renal cell cancer	0.5mg / 0.25mg / 0.75mg / 2.5mg / 5mg / 7.5mg / 10mg	Tablets
Exemestane (film coated)	Breast cancer	25mg	Tablets
Finasteride	Benign prostatic hyperplasia	1mg / 5mg	Tablets
Fludarabine Phosphate	Cancers of blood cells(hematological malignancies)	10mg / 50mg	Tablets
Flutamide	Prostate cancer	250mg	Tablets
Gefitinib	Breast,lung cancers.	250mg	Tablets
Granisetron Hydrochloride	Chemotheraphy	1mg	Tablets
Ibandronate sodium	Osteoporosis &Bisphosphonate	50mg	Tablets
Imatinib mesylate	Multiple cancers	100mg / 400mg	Tablets
Lapatinib	Breast cancer	250mg	Tablets
Letrozole	Breast cancer	2.5mg	Tablets
Mechlorethamine	Hodgkins diseases,lymphomas & leukemias	2mg	Tablets
Megestrol acetate	Breast,endometrial & Prostate cancers	40mg	Tablets
Melphalan	Ovarian cancer	2mg/5mg	Tablets
Mercaptopurine (6-mercaptopurine, 6-MP)	Immunosuppresant,leukemia &non-Hodgkins lymphoma	50mg	Tablets
Methotrexate	Different cancers	2.5mg / 7.5mg	Tablets
Mitotane	Pituitary dependent Cushing's syndrome in canines	500mg	Tablets
Pazopanib	Ovarian cancer	200mg	Tablets
Sorafenib	Kidney cancer	200mg	Tablets
Tamoxifen citrate	Harmone receptor positive Breast cancer	10mg / 20mg / 30mg & 40mg	Tablets
Tegafur-uracil (Ftorafur)	Bowel cancer	50mg / 100mg	Tablets
Thioguanine	Non lymphocyctic leukemia	40mg	Tablets
Toremifene Citrate	Breast cancer(metastatic)	60mg	Tablets
Altretamine	Ovarian cancer	50mg	Capsules
Bexarotene	T-cell lymphoma	75mg	Capsules
Cyclophosphamide	Different cancers & Auto immune disorders	25mg / 50mg	Capsules
Estramustine	Prostate cancer	140mg	Capsules
Etoposide	Anti cancer drug	25mg / 50mg / 100mg	Capsules
Flutamide	Prostate cancer	125mg	Capsules
Hydroxyurea	Sickle cell anemia	500mg	Capsules
Imatinib Mesylate	Multiple cancers	100mg / 400mg	Tablests
Isotretinoin	Brain cancers,Pancreatic & other cancers	10mg / 20mg / 40mg	Capsules
Lenalidomide	Different cancers	2.5mg / 5mg / 10mg / 15mg / 20mg / 25mg	Capsules
Lomustine	Chemotheraphy	10mg / 40mg / 100mg	Capsules
Mycophenolate mofetil	Immunosuppresant,Myelosuppressant	250mg	Capsules
Nilotinib	Chronic myelogenous leukemia	150mg / 200mg	Capsules
Procarbazine	Brain cancers	50mg	Capsules
Semustine	Cancer Chemotheraphy	10mg	Capsules
Sunitinib malate	Anti cancer drug	12.5mg / 25mg / 50mg	Capsules
Tacrolimus	Immunosuppresant	0.5mg / 1 mg / 5 mg	Capsules
Tamsulosin Hydrochloride with Dutasteride	Benign prostatic hyperplasia	400mcg + 500 mcg / 0.5mg/0.4mg	Capsules
Tamsulosin hydrochloride MR	Benign prostatic hyperplasia	0.4mg	Capsules
Temozolomide	Skin cancers	5mg / 20mg / 100mg / 140mg / 180mg / 250mg	Capsules
Thalidomide	Different cancers,Multiple myeloma	50 mg / 100mg / 150mg / 200mg	Capsules
5-fluorouracil	Different cancers(suicide inhibitors)	250mg / 500mg	Injection
Aflibercept	Metastatic colorectal cancer	2mg/0.05ml / 100mg/4ml / 200mg/8ml	Injection
Amifostine	Cancer chemotheraphy & radiotheraphy	500mg	Injection
Asparaginase	Acute lymphoblastic leukemia.	3750iu/5ml / 5000iu / 10 / 000iu	Injection
Azathioprine Sodium	Immunosuppresant,Autoimmune	100mg/vial	Injection
Bendamustine	Chronic lymhocytic leukemia & lymphomas	25mg/vial / 100mg/vial	Injection
Bleomycin	Testicular cancer	15 units / 30 units	Injection
Bortezomib	Multiple myeloma&mantle cell lymphoma	3.5mg/vial	Injection
Busulfan	Chronic lymhocytic leukemia	10ml(6mg/ml)	Injection
Calcium folinate	Cancer Chemotheraphy	100mg/10ml / 300mg/30ml	Injection
Carboplatin	Different cancers(ovarian,lung,head,neck)	150mg / 450mg / 10mg/vial / 50mg/vial	Injection
Carmustine	Brain cancers,chemotheraphy	100mg	Injection
Cisplatin	Anti cancer drug	10mg / 50mg	Injection
Cyclophosphamide	Different cancers & Auto immune disorders	0.2g / 0.5g / 1g / 2g / 200mg / 500mg / 1000mg	Injection
Cytarabine	Cancer of white blood cells	1g / 100mg / 500mg / 100mg/ml	Injection
Cytarabine hydrochloride	Treatment of cancers of White blood cells	50mg	Injection
Dacarbazine	Different cancers(malignant melanoma,Hodgkin lymphoma,sarcoma)	100mg / 200mg / 500mg / 1000mg / 1g	Injection
Daunorubicin	Different cancers like leukemia(acute myeloid leukemia & lymphocyctic leukemia)	200mg	Injection
Docetaxel	Breast,Ovariun,Prostate & non-small cell lung cancer,head,neck,Gastric,Bladder cancers	20mg / 80mg / 120mg /	Injection
Doxorubicin Hydrochloride	Cancer chemotheraphy	10mg / 50mg	Injection
Epirubicin hydrochloride	Breast cancers(chemotherapy)	2mg/ml / 10mg / 50mg / 100mg/ml	Injection
Eribulin Mesylate	Metastatic breast cancer	1 mg/2mL (0.5 mg/mL)/ vial.	Injection
Etoposide	Anti cancer drug	100mg/5ml	Injection
Etoposide hydrochloride	Anti cancer drug	2mg/ml / 100mg/ml	Injection
Fludarabine	Hematological malignancies(cancer of blood cells)	50mg	Injection
Fludarabine Phosphate	Cancers of blood cells(hematological malignancies)	50mg / 250mg	Injection
Fluorouracil	Different cancers(suicide inhibitors)	250mg/5ml	Injection
Fulvestrant	Breast cancer	250mg	Injection
Gemcitabine hydrochloride	Chemotheraphy	200mg / 1000mg	Injection
Gemtuzumab ozogamicin	Acute myelogenous leukemia	5mg/vial	Injection
Granisetron hydrochloride	Chemotheraphy	3mg/3ml	Injection
Ibandronate	Osteoporosis &Bisphosphonate	6mg	Injection
Ibritumomab tiuxetan	B-cell non Hodgkin's lymphoma	3.2mg/2ml	Injection
Ifosfamide	Different cancers(testicular,breast,lung,ovarian,cervical cancers)	500mg / 1000mg / 2000mg	Injection
Ifosfamide	Anti cancer drug	0 .5g / 1g / 2g / 500mg / 1000mg	Powder for Injection
Irinotecan	Colon cancer	20mg/ml / 40mg/2ml / 100mg/5ml	Injection
Irinotecan lyophilized	Colon cancer	40mg / 100mg	Injection
Leucovorin Calcium	Cancer chemotheraphy	3mg/1ml / 7.5mg/1ml / 10mg/1ml / 15mg/1ml & 50mg/5ml	Injection
Leuprolide Acetate	Prostate or Breast cancers	3.75mg / 1mg/ml	Injection
Mechlorethamine	Prostate cancer	10mg/vial	Injection
Mesna	Cancer Chemotheraphy	400mg/4ml	Injection
Methotrexate	Different cancers & Autoimmune disorders	5mg / 100mg / 1g / 50mg/2ml	Injection
Mitomycin	Anal cancer,Breast cancer	2mg / 10mg	Injection
Mitoxantrone	Metastatic breast cancer,Acute myeloid leukemia &non-Hodgkin's lymphoma.	2mg/ml / 20mg/10ml	Injection
Mitoxantrone HCL (Lyophilized Powder)	Metastatic breast cancer,Acute myeloid leukemia &non-Hodgkin's lymphoma.	5mg / 20mg	Injection
Nelarabine	T-cell acute lymphoblastic leukemia	250 mg/50 mL (5 mg/mL) vial	Injection
Octreotide(analogue of somatostatin)	Anti cancer drug	0 .2mg/ml	Injection
Ondansetron hydrochloride	Cancer chemotherapy, radiation therapy, and surgery	4mg /2ml / 8mg/4ml	Injection
Oxaliplatin	Cancer Chemotheraphy	50mg / 100mg / 30mg/5ml / 100mg/16.7ml.	Injection
Paclitaxel	Cancer Chemotheraphy	150mg/25ml / 300mg/50ml	Injection
Palonosetron	Chemotheraphy	0.25mg / 0.25mg/5ml / 0.25mg/50ml	Injection
Pegaspargase	Acute lymphoblastic leukemia.	3 / 750 IU/5 mL single-use vial	Injection
Pemetrexed	Pleural mesothelioma &non-small cell lung cancer	100mg / 500mg	Injection
Pemetrexed disodium	Pleural mesothelioma &non-small cell lung cancer	100mg / 500mg	Injection
Pralatrexate	Peripheral T-cell lymphoma	20mg / 1mL / 40mg / 2mL	Injection
Progestin	Prostate cancer,breast cancer,renal cell carcinoma,endometrial cancer.	150mg/30ml	Injection
Rasburicase	Hematologic cancers(leukemias,lymphomas)	6mg	Injection
Sargramostim	Acute myeloid leukemia	500mcg	Powder for Injection
Teniposide	Acute lymphoblastic leukemia.	50mg/5ml	Injection
Topotecan hydrochloride	Ovarian cancer, Lung cancer	2mg / 2.5mg 4mg	Injection
Vinblastine Sulphate	Different cancers(Hodgkins lymphoma,non-small cell lung cancer,breast,head,neck &testicular cancer.	1mg/ml / 10mg/ml	Injection
Vincristine	Cancer chemotheraphy	1mg / 1mg/ml	Injection
Vincristine sulphate	Cancer Chemotheraphy	1mg/ml / 5mg/ml	Injection
Vindesine sulfate	Different cancers(leukaemia,lymphoma,melanoma,breast &lung cancers).	1mg / 2mg / 4mg	Powder for Injection
Vinorelbine tartrate	Different cancers(breast &non-small cell lung cancers)	10mg/ml / 10mg/1ml / 50mg/5ml	Injection
Vinpocetine	Cerebrovascular disorders	10mg / 20mg / 30mg	Injection
Zoledronic Acid	Prostate cancer,Multiple myeloma	4mg / 5mg/100ml	Injection

While this vision is an aspiration for the future, Taj Pharmaceuticals has begun pioneering the path, with a wide range of products and services available to:

• Oncology Brands
• Oncology Generics
• Therapeutic Division
• Generic Index

GENERIC CONCEPT

Brand	Generic	Therapeutic Category	Strengths	Dosage
Brutrax	Anastrozole	Breast cancer	1mg	Tablets
Raxcomide	Bicalutamide	Prostate cancer	50mg	Tablets
Raxcomide	Bicalutamide	Prostate cancer	150mg	Tablets
Xlotabin	Capecitabine	Metastatic breast & colorectal cancers	150mg	Tablets
Xlotabin	Capecitabine	Metastatic breast & colorectal cancers	500mg	Tablets
Melacyte	Erlotinib Hydrochloride	Pancreatic,non-small cell lung cancer.	100mg	Tablets
Melacyte	Erlotinib Hydrochloride	Pancreatic,non-small cell lung cancer.	150mg	Tablets
Trosgain	Finasteride	Benign prostatic hyperplasia	5mg	Tablets
Trosgain	Finasteride	Benign prostatic hyperplasia	1mg	Tablets
Refta	Gefitinib	Breast,lung cancers.	250mg	Tablets
Tyronib	Imatinib mesylate	Multiple cancers	400mg	Tablets
Sarcomat	Letrozole	Breast cancer	2.5mg	Tablets
Tolvamox	Tamoxifen citrate	Harmone receptor positive Breast cancer	10mg	Tablets
Tolvamox	Tamoxifen citrate	Harmone receptor positive Breast cancer	20mg	Tablets
Brufaze	Etoposide	Anti cancer drug	50mg	Capsules
Tharolax	Hydroxyurea	Sickle cell anemia	500mg	Capsules
Tyronib	Imatinib Mesylate	Multiple cancers	100mg	Tablets
Lymphomus	Tacrolimus	Immunosuppresant	5 mg	Capsules
Lymphomus	Tacrolimus	Immunosuppresant	1mg	Capsules
Bphmax Capsule	Tamsulosin Hydrochloride with Dutasteride	Benign prostatic hyperplasia	400mcg + 500 mcg / 0.5mg/0.4mg	Capsules
Vodafur	Tamsulosin Dutasteride	Benign prostatic hyperplasia	400mcg + 500 mcg / 0.5mg/0.4mg	Capsules
Bphmax Tablets	Tamsulosin hydrochloride MR	Benign prostatic hyperplasia	0.4mg	Tablets
Vervemed	Thalidomide	Different cancers,Multiple myeloma	50mg	Capsules
Vervemed	Thalidomide	Different cancers,Multiple myeloma	100mg	Capsules
Norvelzo	Bortezomib	Multiple myeloma&mantle cell lymphoma	3.5mg/vial	Injection
Brufaze	Etoposide	Anti cancer drug	100mg/5ml	Injection

---

Taj Pharma is one of the largest generic pharmaceutical company in India. We hold top positions in different established markets worldwide and are building a strong presence in many emerging generics markets.

Today, we market more than 500 branded and 4600 generics compositions to consumers in more than 40 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products.

At Taj Pharma, we are always ready to meet the challenges of the dynamic global pharmaceutical industry with its numerous and wide-ranging issues – from complex research, development and regulatory conditions to rapidly changing consumer demands.

Our Generics portfolio offers over 1500 products in the major therapeutic areas of gastro-intestinal, cardiovascular, pain management, oncology, anti-infectives, paediatrics and dermatology. Brands like Alzocum®, Benacof, Wallbrurate®, Coversec, Cadrol, Humogen and Merokem enjoy leadership positions in several key markets, including India, Russia & other countries.

Our deep customer relationships, quality medicines and consistently delivered promise make us a trusted brand across the world.

We have capitalized on every opportunity to bring our high-quality products to more people around the world. A synchronized supply chain that leverages our strong product development capabilities, state-of-the-art manufacturing and vertical integration with our own APIs has created a creditable track record of successful launches.

Our generics offerings deliver quality at cost-effective prices in the highly regulated markets of the United States, UK and other Asian countries.

---

TAJ PHARMA GROUP

A dream for new world Anchored in India and committed to its traditional values of leadership with trust, the Taj Pharma Group is spreading its footprint globally through excellence and innovation.

Each operating company in the group develops its international business as an integral element in an overall strategy, depending on the competitive dynamics of the industry in which it operates. For some businesses a focus on the export market remains the priority. For others it is developing a robust presence in domestic markets given growing population of India. And then there are Group companies, a small but growing number, that have global ambitions; additionally, synchronizing these ventures to cater Indian market remains a priority for growth.

Exports from India remain the cornerstone of the Taj Pharma Group’s international business, but different Taj companies are increasingly investing in assets overseas through Greenfield projects (such as in Spain, Germany, Middle East, Africa, Russia, and CIS Countries), joint ventures (in Sri Lanka, UK) and acquisitions.

While individual Taj companies have differing geographical imperatives, the Taj group is focusing on a clutch of priority countries, which are expected to be of strategic importance in the years ahead. The regions are UK, Sri Lanka, the Netherlands, Germany, South Africa, members of the Gulf Cooperation Council, Brazil, Vietnam, Thailand and Taiwan.

Dr. R.K.Singh, Chairman, Taj Pharmaceuticals Limited., sums up the Taj group’s efforts to internationalize its operations thus: “We hope that a several years from now we will spread our wings far beyond India, that we become a global group, operating in many countries, an Indian business conglomerate that is at home in the world, carrying the same sense of trust that we do today." We have already progressed on such efforts by our current presence in more than 40 countries.

Taj Oncology's vision is to become a world class player in oncology through excellence in innovation, discovery of new manufacturing processes / drug delivery mechanisms and consistently high quality of production. 

We commenced operations in 1994 with the inauguration of our ultra-modern facility for the production of generics and formulations for oncology and other therapeutic applications. We are one of the pioneers in India in lyophilization.

We identified, very early, the need for achieving self - sufficiency in formulations as well as in Active Pharmaceutical Ingredients (APIs) , and our achievements reflect this focus. We launched our (APIs) in year 1994 & now have to our credit a number of new manufacturing processes & drug delivery mechanisms.

We have a manufacturing plant located at Tarapur, Thane in Maharashtra State. This facility meets the current Good Manufacturing Practices norms as laid down by the World Health Organization.

Our marketing spans domestic and overseas operations. With a network across the Indian sub-continent and market penetration in several countries across four continents, we are on our way to meeting our target of reaching out to cancer patients, worldwide.

When science and passion connect, innovation happens. The oncology community shares a common mission: to transform the way patients live with cancer and related diseases. At Taj Oncology, we are passionate about the discovery and development of innovative medicines. We seek to provide a broad range of new therapies as well as practical solutions to advance the care of patients.

A dream for new world Anchored in India and committed to its traditional values of leadership with trust, the Taj Pharma Group is spreading its footprint globally through excellence and innovation.

Each operating company in the group develops its international business as an integral element in an overall strategy, depending on the competitive dynamics of the industry in which it operates. For some businesses a focus on the export market remains the priority. For others it is developing a robust presence in domestic markets given growing population of India. And then there are Group companies, a small but growing number, that have global ambitions; additionally, synchronizing these ventures to cater Indian market remains a priority for growth.

Exports from India remain the cornerstone of the Taj Pharma Group’s international business, but different Taj companies are increasingly investing in assets overseas through Greenfield projects (such as in Spain, Germany, Middle East, Africa, Russia, and CIS Countries), joint ventures (in Sri Lanka, UK) and acquisitions.

While individual Taj companies have differing geographical imperatives, the Taj group is focusing on a clutch of priority countries, which are expected to be of strategic importance in the years ahead. The regions are UK, Sri Lanka, the Netherlands, Germany, South Africa, members of the Gulf Cooperation Council, Brazil, Vietnam, Thailand and Taiwan.

Dr. R.K.Singh, Chairman, Taj Pharmaceuticals Limited., sums up the Taj group’s efforts to internationalize its operations thus: “We hope that a several years from now we will spread our wings far beyond India, that we become a global group, operating in many countries, an Indian business conglomerate that is at home in the world, carrying the same sense of trust that we do today." We have already progressed on such efforts by our current presence in more than 40 countries.

With nearly 7,000 employees operating in 55 countries, Taj Oncology has a truly global reach. We have the advantage of extraordinarily talented and globally diverse employees who, through shared goals and different perspectives, are dedicated to transforming the lives of patients living with cancer around the world. We have developed five new practice-changing medicines in the past decade, addressing unmet medical needs in patients worldwide. Our broad pipeline includes 27 new molecular entities in development, targeting key molecular pathways in cancer biology.

We are totally committed to improving the safety and wellbeing of all people who work with us, or come into contact with our operations and products.

BIOSIMILARS

---

Unlike generic chemical medicines where the active ingredients are identical, biosimilars – by definition – are not likely to be identical to the originator biologic. They are highly similar, but not the same. Biosimilars made by different manufacturers differ from the original product and from each other. Biosimilars are not expected to be direct copies of originator biologics and are therefore not the same as generic drugs. Due to the complex structure of biologic medicines and the processes involved in production, biosimilars must be shown on the basis of analytical, non-clinical and clinical data to be similar to an original biologic in terms of structural characteristics, and safety and efficacy. Minor differences with the active ingredient are expected and permitted so long as any such differences are demonstrated not to be clinically meaningful. The patents of a growing number of biologic medicines have already expired or are due to expire, which has led to an increased interest in the development of biosimilars.

---

DEFINING BIOSIMILARS

---

The World Health Organization: A biotherapeutic product which is similar in terms of quality, safety and efficacy to an already licensed reference biotherapeutic product.

The European Medicines Agency: A biological medicine that is developed to be similar to an existing biological medicine (the ‘reference medicine’). When approved, a biosimilar’s variability and any differences between it and its reference medicine will have been shown not to affect safety or effectiveness.

The U.S. Food and Drug Administration: A biological product that is highly similar to a U.S. licensed reference biological product notwithstanding minor differences in clinically inactive components, and for which there are no clinically meaningful differences between the biological product and the reference product in terms of the safety, purity and potency of the product.

---

TAJ ONCOLOGY BIOSIMILARS

• Biosimilars are potential therapeutic alternatives for biologic medicines, and offer the potential for increased access and reduced cost.
• Amgen is a pioneer in the field of biologic medicines. Science-based medicine and patient safety are fundamental to our values.
• Amgen is uniquely equipped to leverage its leading position in biotechnology to produce biosimilars. We currently have six biosimilar molecules in development. We expect to launch the portfolio starting in 2017.
• Amgen’s core business and growth strategy remains focused on discovering, developing and delivering innovative medicines for patients with grievous illness.

Visit Tajoncology.com to learn more about our group of companies

Connecting within the oncology community

Making connections in science and building relationships with people in the oncology community fuels our ability to deliver innovative medicines for patients. More than a decade ago, Taj AG was the first company to form a dedicated global business unit for developing and launching innovative oncology medicines that address the unmet medical needs of patients. This early vision has led to one of the most dynamic portfolios of new products in the marketplace.

Turning scientific possibility into clinical reality

A decade of success in oncology drug development has taught us the value of our connections within the oncology community and their importance to innovation. Together, we explore novel compounds in clinical development, many with potential best-in-class status, aiming to advance or create new standards of care. Our strategy is composed of three elements:

• Targeted research accelerates development and improves results.
• Collaboration leads to breakthroughs.
• Patient-inspired solutions provide more than medicine.

Unique, dedicated global capabilities support our strategy.

GOLD STANDARD™ ORGANIZATION INTRODUCTION

"A generic oncology drug treatment is now available within many of the major cancer typology and this is often the 'gold standard' option for this condition. Opportunities exist to recommend schedules that encourage initiation of treatment with these 'gold standard' generic medicines. This is a positive sign which should increase the uptake of these drugs and potentially generate long-term savings through the use of a safe and effective therapy at an affordable price".

---

Taj Oncology Corporation in the United States qualified for the CEO Cancer Gold Standard™ Accreditation, bestowed for the first time by the CEO Roundtable on Cancer.

Taj Oncology participates in the CEO Roundtable on Cancer with 40 other companies, federal agencies, and nonprofits. Members play a prominent role in the national effort to eradicate cancer, working together to identify opportunities that will:

• Lower the risk of cancer.
• Enable early diagnosis.
• Facilitate better access to the best available treatments.
• Hasten the discovery of novel and more effective diagnostic tools and anticancer therapies.

The CEO Cancer Gold Standard is a series of cancer-related recommendations that address 3 goals:

• Risk reduction
• Early selection
• Quality care

To become accredited, organizations must demonstrate a culture that fosters healthy lifestyles and provides support when a diagnosis of cancer becomes a reality. They also need to provide programs and benefits that lower cancer risk, attempt to detect it earlier, and provide access to high-quality treatment, including clinical trials.

Taj Oncology always has been a leader in these areas. Several of the programs and policies in the Gold Standard criteria were already in place when Taj joined the Roundtable. The Gold Standard encourages Taj Oncology to do an even better job educating its employees about these services and educational opportunities.

Taj Oncology is committed to keeping its employees and their families informed about advances in cancer prevention and treatment, and will continue to enhance and improve the programs and policies that earned the company the Gold Standard accreditation.

Taj Oncology is leading manufacturer of generic oncology products and biosimilars. Through its broad portfolio of products in Taj Pharma basket, oncology subsidiary is most innovative integrated portfolio with focus on affordability of quality products to treat cancer and help patients to see a ray of hope, we constantly strive to make high quality oncology products that offer treatment to cancer patients and improve the overall quality of life by reducing healthcare costs.. Taj Oncology’s quality system functions as a filter on every level to ensure our products are of excellent quality and exceed the requirements and specifications of our customers and their governments. As an American managed company, we place extreme importance on ensuring all of our products meet the highest standards of quality.

Supplier, exporter and manufacturer of pharmaceutical intermediates, pharmaceutical products, bulk drug, drug intermediate, active pharmaceuticals..

• Pharmaceutical Manufacturers & Wholesalers in Andheri East
• Pharmaceutical Manufacturers & Wholesalers in Kalbadevi
• Pharmaceutical Manufacturers & Wholesalers in Andheri West
• Pharmaceutical Manufacturers & Wholesalers in Worli

Searches related to taj pharma mumbai

taj pharma contact

taj pharmaceuticals products

taj pharmaceuticals turnover

taj pharmaceuticals limited ahmedabad

taj pharmaceuticals wiki

taj pharmaceuticals manufacturing unit

taj pharmaceuticals ceo

taj pharma ahmedabad.
Taj Pharmaceuticals Limited is a Public incorporated. It is classified as Non-govt company and is registered at Registrar of Companies, Mumbai. I

POPULAR TAJ PHARMA PRODUCTS PRODUCTS TAJ PHARMA OTC PRODUCTS IN INDIA TAJ PHARMA PRODUCT LISTTAJ PHARMA PRODUCTS TAJ PHARMA PRODUCTS IN INDIA TAJ PHARMA PRODUCTS SEARCH RESULTS

taj pharma contact, taj pharmaceuticals products, taj pharmaceuticals turnover taj pharmaceuticals limited mumbai taj pharmaceuticals manufacturing unit

taj pharmaceuticals wiki taj pharmaceuticals api list taj pharmaceuticals ceo

taj pharma Taj Pharma defence taj pharmaceuticals limited: Bomaby High Court denies promoters Bomaby High Court denies taj pharmaceuticals limited: promoters High Court taj pharmaHC Disposed 'Copycat Drug' Claims and all Accusations Dropped Between Emcure Pharmaceuticals and Taj Pharmaceuticals. MUMBAI, 

Taj Pharma Group Taj Pharmaceuticals Taj Pharmaceuticals Ltd. Taj Pharma Group, a Mumbai-based leading generic

Taj Pharma  Companies, Taj Pharma  Top Generics, taj  pharmaceutical Pharma taj exporter, taj pharmaceutical drugs supplier, taj pharmaceutical mumbai supplier, active pharmaceutical taj phamra manufacturers, pharmaceutical taj exporter